AVTX
AVTX
NASDAQ · Biotechnology

Avalo Therapeutics Inc

$7.76
+0.06 (+0.78%)
As of Nov 15, 10:34 PM ET ·
Day Range $7.45 — $7.94
52W Range $6.53 — $24.27
Open$7.73
Previous Close$7.70
Day High$7.94
Day Low$7.45
52W High$24.27
52W Low$6.53
Volume—
Avg Volume1.99M
Market Cap453.04M
P/E Ratio—
EPS$-4.75
SectorBiotechnology

Analyst Ratings

Strong Buy
20 analysts
18 Buy 2 Hold 0 Sell
Price Target +324.1% upside
Current
$7.76
Target
$32.91
$27.78 $32.91 avg $47.11

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 258.9K 1.74M 36.29M
Net Income -343,489,587 -2,083,157,872 8.09M
Profit Margin -132,642.4% -126,010.3% 22.3%
EBITDA -318,572,177 -2,039,377,143 9.50M
Free Cash Flow — — 4.67M
Rev Growth -85.2% -85.2% +16.8%
Debt/Equity 0.03 0.03 0.47

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $465.67 -0.30% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $538.60 -0.74% 33.9 134.82B
REGN Regeneron Pharmaceuticals $955.47 +0.45% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $165.04 +5.36% 7.7 20.98B

Quick Stats

Market Cap453.04M
P/E Ratio—
EPS$-4.75
Volume—
SectorBiotechnology